Computable features required to evaluate the efficacy of drugs and a universal algorithm to find optimally effective drug in a drug complex.
<h4>Background</h4>The H1N1 pandemic in 2009 and the H5N1 pandemic in 2005 demonstrated that the drugs approved to treat influenza A viruses have low efficacy. This provided a stimulus for new studies of influenza A viruses in the context of the methods used in drug design developed over...
Guardado en:
Autores principales: | Kui Wang, Wei Cui, Gang Hu, Jianzhao Gao, Zhonghua Wu, Xingye Qiu, Jishou Ruan, Yi Feng, Zhi Qi, Yiming Shao, Jack A Tuszynski |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d70c114404bf4ed28d24eceebff12f76 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The molecular mechanism of action of the CR6261-Azichromycin combination found through computational analysis.
por: Wei Cui, et al.
Publicado: (2012) -
PPAR-alpha agonists as novel antiepileptic drugs: preclinical findings.
por: Monica Puligheddu, et al.
Publicado: (2013) -
Machine Learning-Based Prediction of Drug-Drug Interactions for Histamine Antagonist Using Hybrid Chemical Features
por: Luong Huu Dang, et al.
Publicado: (2021) -
Azvudine, a novel nucleoside reverse transcriptase inhibitor showed good drug combination features and better inhibition on drug-resistant strains than lamivudine in vitro.
por: Rui-Rui Wang, et al.
Publicado: (2014) -
Drugs
Publicado: (1971)